Publications by authors named "J E Luijten"
Introduction: Spinal neurostimulation is a therapy for otherwise intractable chronic pain. Spinal neurostimulation includes stimulation of the spinal cord (SCS), dorsal root ganglion (DRGS), and dorsal root entry zone (DREZS). New paresthesia-free neurostimulation paradigms may rely on different mechanisms of action from those of conventional tonic neurostimulation.
View Article and Find Full Text PDFIn current virtual reality settings for motor skill training, only visual information is usually provided regarding the virtual objects the trainee interacts with. However, information gathered through cutaneous (tactile feedback) and muscle mechanoreceptors (kinesthetic feedback) regarding, e.g.
View Article and Find Full Text PDFBackground: Vesico-ureteral reflux (VUR) is a common associated urological anomaly in anorectal malformation (ARM)-patients. High-grade VUR requires antibiotic prophylaxis to prevent urinary tract infections (UTI's), renal scarring and -failure. The exact prevalence of high-grade VUR in ARM patients is unknown.
View Article and Find Full Text PDFMultimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study.
Ann Surg Oncol
March 2024
Article Synopsis
- Signet ring cell carcinoma (SRCC) and diffuse type adenocarcinoma of the stomach and gastroesophageal junction have poor prognosis, and the impact of neoadjuvant chemotherapy (nCT) and chemoradiotherapy (nCRT) on patient outcomes is uncertain.
- A study analyzed data from 2046 patients with diffuse type carcinoma, comparing those who received nCT versus those who underwent primary surgery, finding that nCT significantly reduced all-cause mortality both within 90 days and beyond after surgery.
- The research concluded that nCT is associated with improved survival rates for patients with gastric and gastroesophageal junction cancers, including those with SRCC.
Background: As previous studies showed significant hospital variation in curative treatment of esophagogastric cancer, this study assesses the association between this variation and overall, cancer-specific and recurrence-free survival, and Health-Related Quality of Life (HRQoL).
Methods: Patients diagnosed with potentially curable esophageal or gastric cancer between 2015 and 2018 as registered in the Netherlands Cancer Registry were included. Data on overall survival was available for all patients, data on cancer-specific and recurrence-free survival and HRQoL was available for subgroups.